$38M

University of Pittsburgh Medical Center — $38M Stark Law Settlement

W.D. Pa. · May 10, 2024 · False Claims Act · Stark Law · DOJ declined intervention

What happened

In May 2024, the University of Pittsburgh Medical Center (UPMC) agreed to pay $38 million to resolve a False Claims Act lawsuit that had been pending for twelve years. The structural fact that distinguishes this case from every other in the ArrowISE enforcement library: the Department of Justice declined to intervene. The settlement was secured entirely by the qui tam relator team and their counsel. It is believed to be among the largest Stark Law-based FCA recoveries ever obtained in a case where the government did not take over the litigation.

The underlying allegations target UPMC's Department of Neurological Surgery. The relators alleged that UPMC paid its neurosurgeons base salaries and productivity bonuses that resulted in total compensation well above fair market value, structured so that the more procedures the neurosurgeons performed at UPMC facilities, the higher their compensation became. The compensation, in other words, was alleged to vary directly with the volume and value of referrals to the hospital system — the specific structural element the Stark Law's employed-physician exceptions prohibit.

The Bookwalter relators and the 12-year arc

The qui tam was filed in 2012 by three relators:

Beyond the Stark Law claims, the relators alleged that some neurosurgeons submitted claims for assisting with procedures they had not actually assisted with or supervised, and that at least one neurosurgeon submitted fraudulent claims for spinal decompression levels that were not performed. The compensation- arrangement claims survived to settlement; the individual-billing-fraud claims were part of the broader litigation.

The case's most consequential moment was not the settlement itself but the appellate decision four years prior. In 2019, the Third Circuit reversed the district court's dismissal of the case in United States ex rel. Bookwalter v. UPMC, 946 F.3d 162 (3d Cir. 2019), holding that a hospital's compensation plan can violate the Stark Law if total compensation varies with or takes into account the volume or value of referrals — even when the formula's labeled components are productivity-based. The decision did not establish entirely new law, but it sharpened the test in a way that hospital systems across the country took seriously enough to re-evaluate their physician compensation structures.

UPMC argued throughout the litigation that the compensation and bonus packages were "industry standard." The settlement contains no admission of wrongdoing. The relators received approximately $11 million29% of the total recovery, a notably high relator share that reflects the DOJ's non-intervention and the relators' resulting full responsibility for case prosecution.

Why this matters — for compliance officers

Three things compliance officers at hospitals and health systems should hold onto from this case:

1. DOJ non-intervention is not safety. Many compliance programs implicitly treat the government's decision not to intervene as a signal that the case will quietly die. UPMC proves the opposite. Well-funded relators with strong appellate-level facts can sustain Stark Law FCA litigation for a decade or more without DOJ participation and recover at settlement-record scale. The structural lesson: a Stark Law arrangement that would not survive scrutiny by a sophisticated relator's counsel does not become safer because the U.S. Attorney declined the case.

2. The Bookwalter holding is the operative test. The Third Circuit's 2019 decision is now controlling precedent in the Third Circuit and persuasive authority elsewhere: total compensation that varies with the volume or value of referrals fails the Stark Law's employed-physician exceptions, regardless of how the underlying formula is labeled. A "productivity bonus" that correlates in practice with referral revenue is the conduct the Bookwalter court reached. Every arrangement's bonus structure should be tested against this framing, not just against the label on the formula.

3. The 12-year litigation horizon changes risk-pricing. A 2012-filed qui tam reached settlement in 2024. Arrangements structured today may not surface as enforcement risk for a decade or more, by which time the original compliance team, legal counsel, and executive leadership may have all turned over. Compliance programs that rely on institutional memory are structurally fragile against this timeframe; only documented, system-of-record arrangement evidence persists reliably across a 12-year window.

What ArrowISE learns from this case

This is a Direct-relevance case. The UPMC fact pattern sits at the analytical center of ArrowISE's domain: employed- physician compensation arrangements where the question is whether total compensation, by its structure or by its practical operation, varies with the volume or value of referrals. The Bookwalter holding sharpens this question legally; ArrowISE's Defensibility Index operationalizes it for compliance officers who need to evidence the answer contemporaneously, not after a 12-year litigation.

Defensibility Index Dimensions Implicated

See the Defensibility Index methodology for how these weights combine into the composite 0–100 score.

Schena-Shield™ pattern rules informed by this case:

Rule ID Pattern detected How ArrowISE addresses it
SS-PA-07 Bookwalter pattern: productivity-labeled bonus formula whose practical operation correlates with referral revenue, even if the formula's named inputs are work-RVU or other apparently-defensible metrics Directly addressed. Extends SS-PA-03 (the volume/value bonus rule from Community Health Network) and SS-PA-06 (the "clinical integration" label rule from Fresno + PNA). The validation tests the bonus formula in operation, not just its labels.
SS-PA-08 Compensation positioned at or above the 75th percentile of national specialty benchmarks without contemporaneous documentation of the productivity, market, or specialty-shortage factors that justify the position Directly addressed. Arrangements at or above the 75th percentile drag the Defensibility Index unless the linked FMV opinion explicitly documents the justification factors. Generic FMV opinions that conclude "compensation is at fair market value" without an element-by-element justification do not satisfy the rule.
SS-PA-09 Aggregate-revenue or aggregate-procedure-volume relationship between physician compensation and the hospital's billing pattern, suggesting compensation in operation tracks referral volume Directly addressed. The Arrangements Registry captures both physician compensation trends and the hospital's billed-procedure trends for the same physician. Statistical correlation above a configurable threshold (default: r > 0.7) generates a Risk-tab alert and drags the Schena-Shield Score.

UPMC is the third Direct case in the ArrowISE enforcement library, after Community Health Network (FMV manipulation through valuation-firm input) and Fresno + PNA (EHR safe-harbor exceedance + "clinical integration" bonus label). Together these three cases establish the structural triad of physician-arrangement enforcement: compensation above FMV, bonus formulas that track referral revenue, and documentation that cannot withstand element-level scrutiny. Every other Direct case in the library — Mercy Health, Memorial Hermann, Banner Health, Akron General, Lehigh Valley — will recombine variants of these three patterns.

The numbers

Total settlement$38 million
Relators' share (29%)~$11.02 million
Government recovery~$26.98 million
DOJ interventionDeclined
Department implicatedUPMC Neurological Surgery (+ 13 named staff neurosurgeons)
Qui tam relatorsJ. William Bookwalter, MD; Robert Sclabassi, MD, PhD; Anna Mitina
Qui tam filed2012
Third Circuit precedentU.S. ex rel. Bookwalter v. UPMC, 946 F.3d 162 (3d Cir. 2019)
Settlement announcedMay 10, 2024
CourtU.S. District Court, Western District of Pennsylvania
Years from qui tam filing to settlement12
The Bookwalter test is the operative standard. Your bonus formulas should pass it. ArrowISE's FMV Sentinel and Safe-Harbor Element Validation test compensation arrangements against the volume-or-value standard the Third Circuit clarified in 2019 — element-by-element, in operation, not just by label.
Book a 30-minute demo
Sources United States ex rel. Bookwalter v. UPMC, 946 F.3d 162 (3d Cir. 2019); settlement announcement, Western District of Pennsylvania, May 10, 2024; Davis Wright Tremaine analysis (June 2024); Feldesman Tucker Leifer Fidell client alert. Last verified 2026-05-12.